[Federal Register Volume 66, Number 178 (Thursday, September 13, 2001)]
[Notices]
[Pages 47674-47675]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-23011]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


White House Commission on Complementary and Alternative Medicine 
Policy; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is given of a meeting of the 
White House Commission on Complementary and Alternative Medicine 
Policy.
    The purpose of this public meeting is to convene the Commission to 
discuss possible Federal policy regarding complementary and alternative 
medicine (CAM). The main focus of the meeting is the discussion of key 
issues before the Commission and the development of draft 
recommendations that may be included in the Final Report of the White 
House Commission on Complementary and Alternative Medicine Policy. 
Major issue areas to be considered by the Commission prior to 
preparation of its Final Report include the following: Coordination of 
CAM Research; Access to and Delivery of CAM Practices and Products; 
Coverage and Reimbursement for CAM Practices and Products; Training and 
Education of Health Care Practitioners in CAM; Development and 
Dissemination of CAM Information for Health Care Providers and the 
Public; CAM in Wellness, Self-Care, Health Promotion, and Disease 
Prevention; Coordinating and Centralizing Private Sector and Federal 
Sector CAM Efforts; and the Definition of CAM and Guiding Principles 
for the preparation of the Final Report from the Commission. Comments 
received at the meeting may be used by the Commission to prepare the 
Report to the President as required by the Executive Order.
    Opportunities for oral statements by the public will be provided on 
October 5, from 5 p.m.-6 p.m. (Time approximate).

    Name of Committee: The White House Commission on Complementary 
and Alternative Medicine Policy.
    Date: October 4-6, 2001.
    Time: October 4--8 a.m.-6--p.m.; October 5--8 a.m.-6 p.m.; 
October 6--8:30 a.m.-12:30 p.m.
    Place: Neuroscience Office Building, National Institutes of 
Health, Conference Rooms C-D, 6001 Executive Boulevard, Bethesda, MD 
20892.
    Contact Persons:Michele M. Chang, CMT, MPH, Executive Secretary; 
OR Stephen C. Groft, Pharm.D., Executive Director, 6707 Democracy 
Boulevard, Room 880, MSC-5467, Bethesda, MD 20892-5467, Phone: (301) 
435-7592, Fax: (301) 480-1691, E-mail: [email protected].
    Because of the need to obtain the views of the public on these 
issues as soon as possible

[[Page 47675]]

and because of the early deadline for the report required of the 
Commission, this notice is being provided at the earliest possible 
time.
    Supplementary Information: The White House Commission on 
Complementary and Alternative Medicine Policy was established on 
March 7, 2000 by Presidential Executive Order 13147. The mission of 
the White House Commission on Complementary and Alternative Medicine 
Policy is to provide a report, through the Secretary of the 
Department of Health and Human Services, on legislative and 
administrative recommendations for assuring that public policy 
maximizes the benefits of complementary and alternative medicine to 
Americans.

Public Participation

    The meeting is open to the public with attendance limited to the 
availability of space on a first come, first served basis. Members 
of the public who wish to present oral comments may register by 
faxing a request to register at 301-480-1691 or by accessing the 
website of the Commission at http://whccamp.hhs.gov no later than 
September 27, 2001.
    Oral comments will be limited to five minutes, three minutes to 
make a statement and two minutes to respond to questions from 
Commission members. Due to time constraints, only one representative 
from each organization will be allotted time for oral testimony. The 
number of speakers and the time allotted may also be limited by the 
number of registrants. Priority may be given to participants who 
have not yet addressed the Commission at previous meetings. All 
requests to register should include the name, address, telephone 
number, and business or professional affiliation of the interested 
party, and should indicate the area of interest or issue to be 
addressed.
    Any person attending the meeting who has not registered to speak 
in advance of the meeting will be allowed to make a brief oral 
statement during the time set aside for public comment if time 
permits, and at the Chairperson's discretion. Individuals unable to 
attend the meeting, or any interested parties, may send written 
comments by mail, fax, or electronically to the staff office of the 
Commission for inclusion in the public record.
    When mailing or faxing written comments, please provide your 
comments, if possible, as an electronic version on a diskette. 
Persons needing special assistance, such as sign language 
interpretation or other special accommodations, should contact the 
Commission staff at the address or telephone number listed above no 
later than September 27, 2001.

    Dated: September 7, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-23011 Filed 9-12-01; 8:45 am]
BILLING CODE 4140-01-M